← Eichor
Study identifier: NCT06963047 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care

Condition: Postpartum Period  ·  Sponsor: Holy Family Hospital, Nazareth, Israel

PhaseNA
Planned participants276
Who can joinFemale, 18 Years to 50 Years
Healthy volunteersYes

About this study

Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after delivery, which are particularly important during the critical period of mother-child bonding. Hemoglobin levels in the first 24 hours after delivery do not reflect the lowest point (nadir). The postpartum nadir occurs 48-72 hours after delivery due to the initial redistribution of plasma volume. The aim of this study was to examine whether postpartum ultrasound examination precedes laboratory test results in the diagnosis of anemia due to blood loss after cesarean section.

This description comes directly from the study's public registry record.

Talk to the study team

Raed Sa, MD  ·  +972544986960  ·  r.salim@hfhosp.org

Bassam Abboud, MD  ·  +972526792999  ·  Dr.bassamabb@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Holy family hospitalNazareth, North, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06963047